Rubens Costa, Haifaa Abdulhaq, Bushra Haq, Richard K. Shadduck, Joan Latsko, Mazen Zenati, Folefac D. Atem, James M. Rossetti, Entezam A. Sahovic and John Lister Activity of azacitidine in chronic myelomonocytic leukemia Cancer 117
Article first published online: 23 DEC 2010 | DOI: 10.1002/cncr.25759
Azacitidine is active in the treatment of CMML. The therapy-associated toxicity is acceptable.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field